Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51,136,131
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
38,123,027
-
Shares change
-
+967,075
-
Total reported value, excl. options
-
$684,323,807
-
Value change
-
+$18,843,309
-
Put/Call ratio
-
130%
-
Number of buys
-
73
-
Number of sells
-
81
-
Price
-
$17.95
Institutional Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2023
As of 31 Dec 2023 REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) had 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,123,027 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, Redmile Group, LLC, STATE STREET CORP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Aquilo Capital Management, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This table shows 202 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.